Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
AKI Therapeutics A/S
A/S
Active
CVR 37509736
Slotsmarken 12, 2970
Hørsholm
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2016 · 10 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
AKI Therapeutics A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
0M
0M
0M
-1M
-1M
2020: 0M
0M
2020
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
EBITDA
DKK millions
0M
-1M
-1M
-2M
-2M
2020: 0M
0M
2020
2021: -2M
-2M
2021
2022: -1M (+50% vs 2021)
-1M
+50%
2022
2023: -2M (-100% vs 2022)
-2M
-100%
2023
2024: -2M (0% vs 2023)
-2M
0%
2024
Income statement
DKK thousands
Item
2024
2023
2022
2021
2020
Revenue
0
0
0
0
-89
Staff expenses
-0
-0
-0
-0
-0
EBITDA
-1.947
-2.022
-1.313
-1.864
-89
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
-1.947
-2.022
-1.313
-1.864
-89
Net financials
-281
30
-26
-151
240
Profit before tax
-2.227
-1.992
-1.339
-2.016
150
Tax
-267
-284
-221
-492
2
Net profit
-1.960
-1.709
-1.117
-1.524
148
Balance sheet
DKK thousands
Item
2024
2023
2022
2021
2020
Total assets
2.169
1.993
3.321
4.732
1.931
Equity
807
747
2.455
3.573
115
Long-term debt
352
214
148
83
1.224
Short-term debt
1.010
1.032
719
1.076
438
Total debt
1.362
1.246
866
1.159
1.661
Financial ratios
5-year trend
EBITDA margin
<−999 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2020
2024
Equity ratio
37,2 %
This company
38,2 %
Market median
This company
Market median
3% below market
2020
2024
Return on equity
-243,0 %
This company
18,4 %
Market median
This company
Market median
>999% below market
2020
2024
Net profit margin
<−999 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2020
2024
Asset turnover
0,00×
This company
1,12×
Market median
This company
Market median
100% below market
2020
2024
Debt / equity
1,69×
This company
0,62×
Market median
This company
Market median
173% above market
2020
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
More on AKI Therapeutics A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
